NovoCure Limited (NVCR) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Novocure Limited.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.916 Good day and thank you for standing by. Welcome to the Novocare first quarter 2025 earnings 00:00:04.916 -- 00:00:09.081 call. At this time, all participants are in a listen-only mode. 00:00:09.081 -- 00:00:12.624 After the speaker's presentation, there will be a question and answer session. 00:00:12.624 -- 00:00:17.269 To ask a question during the session, you'll need to press star 1 1 on your telephone. 00:00:17.269 -- 00:00:20.753 You will then hear an automated message advising your hand is raised. 00:00:20.753 -- 00:00:24.837 To withdraw your question, please press star 1 1 again. 00:00:24.837 -- 00:00:28.195 Please be advised that today's conference is being recorded. 00:00:28.195 -- 00:00:31.861 I would now like to hand the conference over to your host for today's conference, Ingrid 00:00:31.861 -- 00:00:35.042 Goldberg. Please go ahead. 00:00:35.706 -- 00:00:39.392 Ingrid Goldberg Good morning, and thank you for joining us to review Novocare's first 00:00:39.392 -- 00:00:41.635 quarter 2025 performance. 00:00:41.635 -- 00:00:46.883 I'm on the phone this morning with our Executive Chairman Bill Doyle, CEO Ashley Cordova, 00:00:46.883 -- 00:00:51.310 and CFO Christoph Brockmann. Other members of our leadership team will be available for 00:00:51.310 -- 00:00:55.736 Q&A. For your reference, slides accompanying this earnings release can be found on our 00:00:55.736 -- 00:00:58.427 website www.novicure.com 00:00:58.510 -- 00:01:01.434 on the Investor Relations page under Quarterly Reports. 00:01:01.434 -- 00:01:05.200 Before we start, I would like to remind you that our discussions during this conference 00:01:05.200 -- 00:01:09.105 call will include forward-looking statements, and actual results could differ materially 00:01:09...